Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies.
暂无分享,去创建一个
M S Buchsbaum | G Lynch | N Sicotte | G. Lynch | C. Cotman | E. Teng | M. Buchsbaum | E. Hazlett | J. Wu | H. Chui | N. Sicotte | Joseph C. Wu | J. Kesslak | H. Chui | C W Cotman | J Wu | E Hazlett | J P Kesslak | H Chui | E Teng | Evelyn L. Teng
[1] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[2] O Nalcioglu,et al. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease , 1991, Neurology.
[3] L. DeLisi,et al. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients , 1987, Biological Psychiatry.
[4] P. Colletti,et al. Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer's disease. , 1988, The American journal of psychiatry.
[5] G. Lynch,et al. Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease , 1988, Neurobiology of Aging.
[6] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[7] J. Mazziotta,et al. Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset. , 1989, Archives of general psychiatry.
[8] Prof. Yun Peng Huang,et al. Computed Tomography of the Brain , 1980, Springer Berlin Heidelberg.
[9] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[10] A. Alavi,et al. Alzheimer's disease with prominent visual symptoms. Clinical and metabolic evaluation. , 1989, Ophthalmology (Rochester, Minn.).
[11] B. Reisberg,et al. Positron emission tomographic studies of aging and Alzheimer disease. , 1983, AJNR. American journal of neuroradiology.
[12] Z. Khachaturian. Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.
[13] A. Shetter,et al. Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study. , 1989, Journal of neurosurgery.
[14] G K Wilcock,et al. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[15] G. V. Van Hoesen,et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.
[16] D. Rezek. Olfactory deficits as a neurologic sign in dementia of the Alzheimer type. , 1987, Archives of neurology.
[17] M. Roth,et al. The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.
[18] W. Jagust,et al. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease , 1988, Neurology.
[19] E. Hoffman,et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.
[20] B. Reisberg,et al. Abnormal Temporal Lobe Response in Alzheimer's Disease during Cognitive Processing as Measured by 11C-2-Deoxy-D-Glucose and PET , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] B. L. Beattie,et al. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[22] J. Haxby,et al. Positron emission tomography in Alzheimer's disease , 1986, Neurology.
[23] M. Folstein,et al. The Mini-Mental State Examination. , 1983, Archives of general psychiatry.
[24] R. Doty,et al. Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function , 1984, Physiology & Behavior.
[25] L. DeLisi,et al. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. , 1984, Archives of general psychiatry.
[26] W. Snow,et al. The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease , 1988, Neurology.
[27] D. Benson,et al. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. , 1983, Archives of neurology.
[28] J. Hanaway,et al. Atlas of the human brain in section , 1970 .
[29] J Marshall,et al. Cerebral blood flow in dementia. , 1975, Archives of neurology.
[30] R H Huesman,et al. Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose , 1983, Journal of computer assisted tomography.
[31] Robert P. Friedland,et al. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization , 1985, Neuroscience Letters.
[32] N. Foster,et al. Alzheimer's disease , 1987, Neurology.
[33] A. Burns. Clinical diagnosis of Alzheimer's disease , 1991 .
[34] E. Hoffman,et al. Noninvasive determination of local cerebral metabolic rate of glucose in man. , 1980, The American journal of physiology.
[35] W. Dixon,et al. BMDP statistical software , 1983 .